Flovent HFA (Fluticasone Propionate Inhaler)

Approved for Maintenance treatment of asthma and prevention of bronchospasm in adults and children aged 5 years and older, Maintenance treatment of bronchoconstriction in COPD. Fluticasone propionate is a synthetic corticosteroid that reduces airway inflammation by inhibiting multiple cell types (mast cells, eosinophils, macrophages) and mediators (histamine, leukotrienes,… Side effects, costs,…

Loading full data from Know Your Drugs Institute…